1.Study on Compatibility Stability of Alanylglutamine by Using Continuous Series Infusion Device
Chengliang ZHANG ; Chengyang FENG ; Yanjiao XU ; Zaoqin YU ; Dong LIU
Herald of Medicine 2015;34(12):1657-1659
Objective To investigate the compatible stability of alanylglutamine by using continuous series infusion device,and provide experimental evidence for reasonable clinical use of alanylglutamine. Methods pH,osmolality and quantity of insoluble particles were measured by using pH meter, automatic freezing osmometer and intelligent particle detector respectively.A HPLC method was built for the determination of the content of alanylglutamine. Results pH and quantity of insoluble particles of the two tested groups did not change significantly over time. Osmolality and the content of alanylglutamine fluctuated greatly in the first half an hour. Conclusion Continuous series infusion device may not mix each bottle of solution very well.It is suggested to premix these solutions to ensure the stability of the dilution ratio and the osmotic pressure of the mixture in the process of the infusion.
2.Investigation on the safety and effect of percutaneous transluminal intervention in advance aged patients with angina recurrence after coronary artery bypass grafting
Chengyang LI ; Hong YU ; Xuan WU ; Zhanquan LI ; Xuguang LI
Chinese Journal of Primary Medicine and Pharmacy 2014;(10):1451-1452,1453
Objective To summarize the safety and clinical therapeutic effect of advanced aged coronary heart disease(CHD) patients with angina recurrence after coronary artery bypass grafting (CABG).Methods The clinical data,arteriography and the interventional results of 9 aged patients with angina recurrence treated by CABG were retrospectively analyzed .Results There were 8 patients received intervention ,among them 5 patients received coronary artery intervention , another 3 patients received graft vessels intervention .During operation and hospitaliza-tion,angina recurrence,acute myocardial infarction,revascularization,complication and mortality were not observed in 8 patients who received intervention .All patients were followed up for 12 months,there were 3 patients had angina recurrence and cured by drugs , but had no acute myocardial infarction and revascularization .Conclusion The intervention for advanced aged patients after CABG is a safe and effective treatment .The advanced aged patients with angina recurrence need receive arteriography quickly and receive coronary artery interventional treatment or graft vessels interventional treatment .
3.Clinical evaluation of ureteroscopic endo-incision and drainage in the treatment of renal cysts
Xiaoping WANG ; Zhixiang LAN ; Chengyang LI ; Yaoliang DENG ; Hai YU ; Yanwei HUANG ; Bin HU ; Jinyu YANG
Chinese Journal of Urology 2009;30(3):195-197
Objective To evaluate the efficacy and safety of ureteroscopic endo-incision and drainage in the treatment of renal cysts.Methods Thirty cases(19 females and 11 males)of renal cysts(1 1 parapelvie cysts,15 simple cysts.and 4 multiple cysts)were treated with ureteroscopic endo-incision and drainage.The renal cysts were located in renal pelvis,and opened and decompressed by electrotme with ureteroscope.Double J stent was placed afterwards.Urinary and blood biochemistry were tested post-operatively.Results All the operations were successfully completed with no severe complication.The cyst managing time ranged from 15 tO 45 min.Urinary biochemistry(urinary protein and glucose)turned normal 1 2 days after the surgery.Patients were followed up for 3 to 9 months.Renal cysts disappeared in 24 cases,diminished in 4 cases,and recurred in 2 cases.Conclusion Application of ureteroscopic technique in the treatment of renal cyst is safe,effective and minimally invasive.
4.Research Progress in Bezoar Compound and its Preparations
Wei LI ; Xiping LI ; Chengliang ZHANG ; Yanjiao XU ; Zaoqin YU ; Chengyang FENG
China Pharmacist 2015;18(10):1784-1787
With the advent of bezoar substitutes, bezoar compound has been widely used in clinics. Bezoar is commonly applied in the traditional prescriptions for emergency. Due to the complex compositions and difficult soluble constituents, the prescriptions show the disadvantages of low bioavailability and slow onset in clinical application, and the effectiveness is usually related with the adminis-tration route and characteristics of dosage form of the preparations. The exiting bezoar compound and its new dosage forms were summa-rized in the paper, and the existing bezoar compound preparations were stated according to the characteristics of dosage forms and com-pound clinical application in order to promote the development and application of bezoar new dosage forms.
5.Influence of Mode of Delivery on Children’s Attention Deficit Hyperactivity Disorder and Childhood Intelligence
Min XU ; Xuemei YU ; Benjie FAN ; Guimei LI ; Xinxin JI
Psychiatry Investigation 2023;20(8):714-720
Objective:
To investigate whether differences exist in attention deficit hyperactivity disorder (ADHD) and intelligence between children born by cesarean delivery and those born by vaginal delivery.
Methods:
This retrospective study included singleton children that were born between January 2013 and December 2014. The Chinese version of the Conners’ Parent Rating Scale–Revised (CPRS-48) was required on the probability of psychological and behavioral problems. The China–Wechsler Intelligence Scale for Children (C-WIRS) was used for evaluation of crystallized intelligence and Raven’s Standard Progressive Matrices for evaluation of fluid intelligence.
Results:
A total of 10,568 valid questionnaires were obtained. CPRS-48 ADHD index and detection rate were higher in cesarean delivery group than those in vaginal delivery group. Cesarean delivery groups had a lower performance intelligence quotient score according to C-WISC.
Conclusion
Children born by cesarean delivery were more likely to have a risk of ADHD and a lower performance intelligence quotient compared with those born by vaginal delivery.
6.Combined fibrinogen concentration and neutrophil-lymphocyte ratio as a prognosis indicator for gastrointestinal stromal tumors
Chenmin YE ; Yongdong YI ; Leibin SHEN ; Guojun XIA ; Chengyang YU ; Fuyang TU ; Zhiqiang ZHENG
Chinese Journal of General Surgery 2019;34(4):319-322
Objective To evaluate FIB-NLR,a combined neutrophil-lymphocyte ratio (NLR) and fibrinogen concentration (FIB) in predicting the prognosis of gastrointestinal stromal tumors (GIST).Methods Data of 79 GIST patients who underwent surgery from Jun 2010 to Dec 2014 were retrospectively analyzed.Patients were divided into 3 groups:NLR < 2.30 and FIB < 3.85 g/L were defined as group 0,NLR≥2.30 and FIB <3.85 g/L or NLR <2.30 and FIB≥3.85 g/L as group 1,NLR≥2.30 and FIB≥3.85 g/L as group 2.The clinicopathological features of the three groups and the 5-year recurrence-free survival rate after surgery were compared.Results FIB concentration and NLR were significantly correlated with NIH risk grade and tumor size in GIST patients (x2 =9.517,12.41 1,6.081,20.067,all P < 0.05).FIB-NLR was closely related to tumor size,tumor risk and tumor mitosis (x2 =14.406,12.514,28.225,all P < 0.05).Survival analysis showed that high FIB predicts lower 5-year recurrence-free survival rate,it was 87.4% for group 0,60.8% for group 1,21.1% for group2,x2 =29.617,P<0.000).Conclusion FIB-NLR independently predicts the prognosis of gastrointestinal stromal tumors.
7.Hydrogel loaded with exosomes from Wharton 's Jelly-derived mesenchymal stem cells enhances wound healing in mice.
Cui Bocheng XU ; Zhengbao XU ; Chengyang YU ; Zufu JIANG
Journal of Zhejiang University. Medical sciences 2023;52(6):766-776
OBJECTIVES:
To explore the effect of hydrogel loaded with exosomes from Wharton's Jelly-derived mesenchymal stem cell (WJMSC) on wound healing.
METHODS:
Exosomes were extracted from WJMSC, and the morphology and size of WJMSC-derived exosomes (WEX) were analyzed by transmission electron microscopy and nanoparticle size analyzer, respectively. The surface markers CD9, CD81, and Calnexin of WEX were detected by Western blotting. Exosome-loaded alginate hydrogel (WEX-gel) was prepared; its morphology was studied by scanning electron microscope, and its rheological behavior was examined by a rheometer. The in vitro drug release performance of WEX-gel was investigated by BCA method. RAW264.7 cells were treated with alginate hydrogel, WEX and WEX-gel, respectively; and the expression of CD86 and CD206 in macrophages was detected by flow cytometry. A full-thickness skin wound model was established in mice; the model mice were randomly divided into blank control group, WEX control group and WEX-gel group, and PBS, WEX and WEX-gel were applied to the wound area of mice, respectively. On day 3, the skin tissue of mice was excised, and the antibacterial effect of WEX hydrogel was evaluated by plate counting. On day 15, the mice were euthanized and the percentage of residual wounds was calculated. The histological changes of the skin wound were observed after hematoxylin and eosin (HE) and Masson stainings. The expression of CD86, CD206, CD31 and vascular endothelial growth factor (VEGF) in the skin wound tissue was detected by immunohistochemistry.
RESULTS:
Exosomes were successfully extracted from WJMSC. WEX-gel presented a regular three-dimensional network structure, good rheology and controlled drug release performance. WEX-gel promoted the polarization of RAW264.7 cells from the M1 phenotype to M2 phenotype in vitro. The residual wound percentage in blank control group, WEX control group and WEX-gel group were (27.5±3.4)%, (15.3±1.2)% and (7.6±1.1)%, respectively (P<0.05). The antibacterial property of WEX-gel is better than that of WEX (P<0.05). The dermis thickness, the number of new hair follicles, and the rate of collagen deposition in the WEX-gel group were significantly higher than those in the other two groups (all P<0.05). The expression of CD206, CD31 and VEGF in skin wound tissue was higher and the expression of CD86 was lower in WEX-gel group than those in other two groups (all P<0.05).
CONCLUSIONS
WEX-gel can significantly promote wound healing in mice by regulating the polarization of macrophages.
Mice
;
Animals
;
Vascular Endothelial Growth Factor A
;
Wharton Jelly
;
Exosomes
;
Hydrogels
;
Wound Healing/physiology*
;
Mesenchymal Stem Cells
;
Anti-Bacterial Agents
;
Alginates
8.Mean Corpuscular Volume Can Be A Predictor for Therapeutic Response of Patients with Chronic Myeloid Leukemia.
Luo LU ; Chun QIAO ; Ming HONG ; Yan-Ru LI ; Liang-Qin PAN ; Si-Xuan QIAN ; Yu ZHU ; Jian-Yong LI
Journal of Experimental Hematology 2018;26(2):382-388
OBJECTIVEThe past studies found that the treatment of chronic myeloid leukemia (CML) with imatinib can induce the macrocytic anemia, moreover the incidence of anemia increases along with enhancement of imatinib concentration. This study was aimed to evaluate the potential relation of erythrocyte mean corpuscular volume (MCV) increase after the treatment with tyrosine kinase inhibitors (TKI) with the therapeutic response in patients with CML-chronic phase (CML-CP).
METHODSThe clinical and hematologic data including MCV, molecular and cytogenetic response of 119 patients with CML-CP were collected after treatment with TKIs, and the relation of MCV changes after treatment with the clinical characteristics and therapeutic efficacy for patients with CML-CP was analyzed.
RESULTSThe MCV in patients treated with TKIs for 12 months significantly increased as compared with that at initial diagnosis (P<0.05). The proportion of patients with increased MCV in group of complete cytogenetic response (CCyR) was significantly higher than that in group of non-CCyR (P<0.05). As compared with decreased MCV group, the patients in increased MCV group much more easily achieved CCyR after treatment for 6, 12 months (P<0.05, P<0.05) respectively, furthermore, much more easily maintained MMR (P<0.05).
CONCLUSIONThe MCV as a parameter which is easily acquired may be a new marker for prodecting the therapeutic response of patients treated with TKIs.
Antineoplastic Agents ; Erythrocyte Indices ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive ; Protein Kinase Inhibitors ; Treatment Outcome